Technology Development for the Detection and Evaluation of Chemical and Biological Carcinogens (SBIR) [R43/R44]

The summary for the Technology Development for the Detection and Evaluation of Chemical and Biological Carcinogens (SBIR) [R43/R44] grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Technology Development for the Detection and Evaluation of Chemical and Biological Carcinogens (SBIR) [R43/R44]: Purpose. This Funding Opportunity Announcement (FOA) issued by the National Cancer Institute (NCI) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop new technologies and/or improve existing technologies for the detection and evaluation of chemical and biological carcinogens in clinical and/or environmental specimens. These technologies should be amenable to automation and high sample throughput. The ultimate goal of this initiative is to develop innovative carcinogen detection technologies to the stage of commercially viable assays.
Federal Grant Title: Technology Development for the Detection and Evaluation of Chemical and Biological Carcinogens (SBIR) [R43/R44]
Federal Agency Name: National Institutes of Health
Grant Categories: Health Education
Type of Opportunity: Discretionary
Funding Opportunity Number: PAS-07-240
Type of Funding: Grant
CFDA Numbers: 93.396
CFDA Descriptions: Cancer Biology Research
Current Application Deadline: No deadline provided
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: Mar 06, 2007
Creation Date: Mar 06, 2007
Archive Date: Feb 02, 2008
Total Program Funding: $1,400,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Foreign institutions are not eligible to apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Revision Applications for Mechanisms of Drug Resistance (P50 Clinical Trials Not Allowed)
Revision Applications for Mechanisms of Drug Resistance (P01 Clinical Trials Not Allowed)
Revision Applications for Mechanisms of Drug Resistance (U54 Clinical Trials Not Allowed)
Revision Applications for Mechanisms of Drug Resistance (U01 Clinical Trials Not Allowed)
Revision Applications for Mechanisms of Drug Resistance (R01 Clinical Trials Not Allowed)
Mouse Models of Human Cancers Consortium
Integrative Cancer Biology Programs
Memory T Lymphocytes in Cancer Immunology (R21)
More Grants from the National Institutes of Health
Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2020 FederalGrants.com